Get the Daily Brief
Latest Biotech News
Groundbreaking Research Uncovers Novel Disease Mechanisms and Therapeutic Targets
Recent studies are elucidating complex biological mechanisms to inform disease treatment. Discoveries include the role of SET8 protein in enhancing prognosis and radiotherapy in lung...
Genmab to acquire Merus for $8 billion in cancer pipeline expansion
Genmab has agreed to acquire Dutch biotech Merus for approximately $8 billion in a deal designed to bolster its cancer treatment pipeline with a late-stage bispecific antibody, petosemtamab. The...
Pfizer’s drug pricing deal under Trump’s most-favored nation plan
Pfizer has become the first pharmaceutical company to agree to the Trump administration’s most-favored nation (MFN) drug pricing policy, committing to price its products in the U.S. in line with...
AI and computational advances accelerate biotech research and diagnostics
Several breakthroughs highlight artificial intelligence and computational innovations transforming biotechnology and medical diagnostics. A new AI-driven framework automates lymph node...
New clinical trial data in oncology and immunotherapy
Multiple significant clinical trial results have emerged across oncology disciplines. NRG Oncology’s Phase II data shows proton therapy combined with emission correlates with enhanced survival in...
Advances in neurodegenerative disease and brain health research
Recent studies provide significant insights into neurological disorders and brain health. Research into Parkinson’s disease reveals thalamic volume shifts correlating with cognitive and motor...
Breakthroughs in genome editing and CRISPR system evolution
Groundbreaking research is elucidating the origins and functional evolution of CRISPR systems critical to genome editing technology. A new study reveals an RNA splitting mechanism that drove the...
Microbiome and infectious disease: impacts of drugs and diagnostics
Emerging research highlights profound interactions between drug use and microbiome dynamics with implications for diagnostics and treatment. A large Estonian cohort study found that various...
Innovations in radiation oncology for cancer treatment and patient outcomes
Radiation oncology is witnessing technological advances improving cancer treatment efficacy and patient quality of life. A decade-long trial reveals that stereotactic radiation therapy matches...
Novel materials and energy storage technology breakthroughs
Research in materials science and energy storage has yielded transformative innovations potentially impacting future sustainable technologies. Advances include the development of recyclable...
Pfizer and Trump Announce Most-Favored Nation Drug Pricing Deal
Pfizer has agreed to a most-favored nation drug pricing deal aimed at aligning U.S. drug prices with those in other developed nations. Under this plan, newly launched Pfizer drugs will be priced...
Genmab Acquires Merus for $8 Billion to Expand Bispecific Antibody Pipeline
Genmab has agreed to acquire Dutch biotech Merus for approximately $8 billion in cash, aiming to bolster its late-stage oncology pipeline with Merus’ bispecific antibody, petosemtamab. The drug...
New AI and Machine Learning Tools Advance Biomedical Data Analysis
Innovations in artificial intelligence and machine learning are accelerating biomedical research by improving data analysis capabilities. Tools such as ROCS X by Cadence Molecular Sciences enable...
Promising Clinical and Preclinical Advances in Cancer Therapeutics
Recent studies have highlighted notable progress in cancer treatment approaches. Novel immunotherapy scaffolds and bispecific antibodies show potential for difficult cancers such as glioblastoma...
Innovations in Imaging and Diagnostic Technologies for Oncology and Neurology
Breakthrough diagnostic imaging and biomarker technologies are improving clinical management of complex diseases. The TriVerity biomarker test outperforms established infection markers for sepsis...
Advances in Microbiome Research and Infectious Disease Understanding
Groundbreaking research continues to elucidate the role of microbiota and pathogens in health and disease. The gut microbiome shows lasting alterations in response to past medication usage,...
Breakthroughs in Cell and Molecular Biology Expanding Disease Insights
Innovative studies have uncovered critical molecular and cellular mechanisms across various diseases. Senescent cells are characterized as metabolically active yet dysfunctional contributors to...
Emerging Therapeutics and Clinical Trends in Pulmonary and Cardiovascular Diseases
New research highlights promising therapeutic interventions in respiratory and cardiovascular conditions. Biologic therapies reduce symptoms and hospitalizations in pulmonary arterial...
Innovations in Cell and Gene Therapy and Bioprocessing Technologies
Recent advances are pushing the boundaries of cell and gene therapy development and manufacturing. Efficient nucleic acid quantitation technologies like Countable PCR improve accuracy for gene...
Genmab Bolsters Oncology Pipeline: $8B Merus Acquisition Completed
Danish biopharmaceutical company Genmab has finalized the $8 billion acquisition of Netherlands-based Merus NV, strategically expanding its cancer treatment portfolio with Merus’ late-stage...